INTRODUCTION
Endotoxins are inflammatory lipopolysaccharide (LPS) molecules from Gram negative bacteria that are ubiquitous in the indoor environment (1) . Endotoxins are amphipathic molecules bearing both polysaccharide and lipid moieties. The Lipid A component of the molecule is conserved across bacterial species and carries the toxic potency. Inhalation exposure to endotoxins is common in occupational environments (2) and in homes (3, 4) . Recognized determinants of endotoxin in homes include indoor sources such as pets, pests, humidifiers, kitchen compost bins, and outdoor air (5) (6) (7) (8) . The hazards of inhaled endotoxin first became apparent from studies of lung disease among workers exposed to vegetable and cotton dust (9, 10) and were later refined with measured endotoxin exposures (11) (12) (13) . Studies in the 1990s characterized pulmonary responses, including lung inflammation and cytokine upregulation, upon inhalation of endotoxin and organic dusts containing endotoxin in humans (14) (15) (16) (17) (18) (19) and mice (17, (20) (21) (22) . Inhaled endotoxins trigger cellular activation and cytokine release from macrophages and other myeloid cells through LPS binding protein and CD14-dependent delivery of monomeric endotoxin to cells expressing MD-2 and TLR4 on their surface (23, 24) . These responses to endotoxin inhalation may differ between individuals by genetics (19) or by degree of developed tolerance (25).
A number of epidemiologic studies have drawn attention to endotoxin exposure in domiciles and its role in asthma. Michel et al. studied endotoxin in settled dust in the homes of patients with stable chronic rhinitis or asthma and noted a significant association of mattress and floor dust endotoxin concentration, but not mite allergen concentration, with the severity of asthma and asthma medication use (3) . Studies from Bavaria (26), Canada (27), and Sweden (28) have provided evidence that growing up on a family farm leaves one less likely to develop allergies and allergic asthma. This protective effect (the hygiene hypothesis) is supported by studies demonstrating a shift away from an allergic phenotype with early life exposure to endotoxin (29). However, studies from Australia (30), Europe (31), New Zealand (32) and the U.S. (33, 34) have found the same or higher asthma rates (i.e. no protective effect) between farm and non-farm children in one or more study groups. The role of endotoxin as a risk factor for asthma and wheezing has been investigated in urban cohort studies (35, 36) with the finding that higher endotoxin in house dust was associated with higher prevalence of wheeze. To date studies relating endotoxin exposure to health outcomes have been limited to one or two locales and may not be representative of a wider geographic area with its associated diversity.
The first national survey of endotoxin in U.S. housing provides a unique opportunity to explore hypotheses regarding the geographical distribution of endotoxin, socioeconomic and housing characteristics related to endotoxin exposure, and the association of endotoxin exposure with asthma and allergy in a representative sample of the United States. The latter is the subject of this report. Some of the results of these studies have been previously reported in the form of an abstract (7) .
MATERIALS AND METHODS

Study Design
This study was conducted using samples collected for the National Survey of Lead and Allergens in Housing. The study design, sampling, and endotoxin analysis methods have been published (37). The study was carried out in 831 housing units representative of the nation's 96 million homes.
Assessment of Health Outcomes
Analyses included seven health outcome variables assessed at the individual level. These were ascertained as described previously (37) and in the online supplement: diagnosed hay fever; diagnosed asthma; asthma symptoms past year; current asthma medication use; and wheezing ever, in the past month, and in the past year. Since exposure data were available by household, health outcomes were aggregated to the household level for primary analysis. Verification analyses were performed at the individual level for adults and children.
Exposure Assessment
Each household was visited by two field workers who administered a detailed questionnaire, conducted a home inspection, and collected samples. The questionnaire included information on demographics and health of the residents plus conditions of the home (37). Dust was sampled by vacuum collection into an in-line filter using a standardized protocol. Dust was sieved (425 µm), aliquoted into 100mg lots and then frozen at -80°C prior to indoor allergen and endotoxin assays.
Endotoxin and allergen analysis methods have been described previously (37).
Briefly, endotoxin was analyzed on 50mg quantities of sieved dust extracted with 1.0ml pyrogen-free water containing 0.05% Tween-20 using the kinetic chromogenic Limulus amebocyte lysate assay (38). Following linkage with housing unit and allergen data, 2512 endotoxin determinations were available for statistical analysis.
Statistical analysis
Logistic regression analyses were performed to assess the effect of the level of endotoxin concentration (EU/mg) on the disease outcomes. Endotoxin was evaluated as a continuous variable in unadjusted logistic models and was dichotomized in adjusted models. Full logistic models were adjusted for census region, season, frequency of indoor cigarette smoking, education, poverty, ethnicity, race, a child younger than 6 years living in the home, as well as exposure to house dust mite, cat and dog allergens. Cutoffs for dichotomization were selected at the first quartile for bedroom floor and family room floor and second quartile for bedding endotoxin, on the basis of smoothing plots of health outcomes versus endotoxin concentration to maximize the strength of association. Models were tested for significant interactions between categorical endotoxin exposure and allergens and none were found. Sample weights were applied to all household level estimates to account for housing unit selection probabilities, non-response, and post-stratification. Taylor series linearization methods were used to obtain variance estimates adjusted for clustering associated with the multi-stage complex survey design. The analyses were conducted in SUDAAN (ver-8.0, RTI, Research Triangle Park, NC).
The relationship between endotoxin and disease outcomes was illustrated graphically, using smoothed plots to exhibit trends in outcome prevalence across a range of concentrations. The relationship was first modeled through nonparametric regression analyses, conducted without weighting or incorporation of survey design information using S-PLUS (Ver-6.2, Insightful Corp., Seattle, WA). The logit of rate of disease outcome was expressed as a continuous function of the log-transformed endotoxin level, obtained using a locally weighted regression smoother while controlling for the covariates mentioned above. The smoothing parameter for each model was selected based on Akaike's information criterion.
Correlations between endotoxin and eight allergens were calculated as Pearson correlation coefficients using log-transformed endotoxin concentration.
RESULTS
Weighted estimates for endotoxin recovered from the five sampling locations were expressed as both endotoxin concentration in the sieved dust (EU/mg) and endotoxin load (EU/m 2 of vacuumed area). For samples recovered from the kitchen floor and family room sofa, the area sampled was variable and so total load (total EU in the sample) was specified. The geometric mean endotoxin values, geometric standard errors, 95% confidence intervals, and 5 th and 95 th percentiles are reported in Table 1 (unweighted values are provided in the online supplement). These data show that concentrations were highest for kitchen floors and living room floors and lowest for the bedding which includes the mattress and pillow. While there was a high degree of variability for kitchen floors, family room floors and sofas, the variability was considerably less for bedding and bedroom floors. It was of interest to explore the relationship of endotoxin concentrations to those of household allergens measured from the same samples to assess the potential for confounding. Correlation coefficients between endotoxin and eight animal, arthropod and fungal allergens in the five household sites were low, ranging from -0.03 to 0.43 (see Table 2 ). Only 5 of the 40 coefficients exceeded 0.30 and 4 of those were for Alternaria alternata, a common species of fungus. We also determined overall Pearson correlation coefficients for endotoxin pairs within the same households (Table 3) . Endotoxin concentrations were not highly correlated between rooms of the same households and coefficients ranged from 0.44 to 0.12.
This study yielded a prevalence rate of 11.3% for diagnosed asthma among persons living in non-institutional U.S. housing that is permanently occupied, noninstitutional, and allows resident children. This compared favorably with the prevalence of diagnosed asthma determined from the 2002 National Health Interview Survey of 11.1% (39). This study also compared favorably for diagnosed asthma when separated by gender and age categories (see the online supplement). Logistic regression analyses were performed without adjustment for health outcomes using log 10 endotoxin as a continuous variable to determine if there is a relationship between household endotoxin and health outcomes (Table 4) . While there was no relationship of endotoxin exposure with hay fever, the relationships between endotoxin and other health outcomes were highly significant for bedroom floor endotoxin. Endotoxin from other sampling locations yielded p values significant or suggestive of an effect for asthma outcomes (p=0.02 to 0.10).
To further explore the role of bedroom and family room endotoxin in asthma,
we developed logistic regression models using dichotomized endotoxin levels ( Table   5 ). Significantly-elevated crude odds ratios were identified with exposure to bedroom floor endotoxin for the following outcomes: asthma symptoms in the past year (OR=2.82), current asthma medication use (OR=2.42), wheezing ever (OR=2.13), wheezing in the past month (OR=1.98), and wheezing in the past year (OR=2.23).
After adjustment, odds ratios were still significantly elevated for most of these outcomes (Table 5) . Similar results (but with lower OR) were observed when the prevalence of disease outcomes was evaluated for association with bedding endotoxin concentration ( Table 5 ). In both the unadjusted and fully adjusted models for bedding, increased endotoxin concentration was most strongly associated with wheezing ever, in the past month, and in the past year. Odds ratios for the effect of family room floor endotoxin on health outcomes were not significant although diagnosed asthma, symptomatic asthma, and taking asthma medication had adjusted OR of 2.0 or more.
It is noteworthy that neither bedroom floor, family room floor, nor bedding endotoxin were protective factors for self-reported doctor diagnosed hay fever, an indicator of atopy.
To understand the effect of aggregation to the household level, we also performed individual level analyses for bedroom floor endotoxin separately for adults ( 18 yrs, 65% of subjects) and children (< 18 yrs). This allowed for adjustment for potential confounders at the individual level. This analysis yielded findings consistent with the household level analysis for adults with significantly elevated adjusted odds ratios for symptomatic asthma and medication use. None of the odds ratios for children were significant and point estimates were generally close to 1.0 demonstrating that the effect of endotoxin was in adults. These results are provided in the online supplement.
Relationships between endotoxin concentration and disease outcomes were assessed using nonparametric regression analysis while controlling for the covariates mentioned above. These smoothed plots are shown in Figure 2 for bedroom floor endotoxin and four health outcomes. There was a marked increase in prevalence with increasing endotoxin for each health outcome. None of the outcome variables demonstrated a threshold below which there was no increase in prevalence with increasing endotoxin. Thus, no level of endotoxin observed in this study could be clearly identified as a no-effect level.
To further evaluate the role of bedroom floor and bedding endotoxin on prevalence of asthma symptoms in the past year, we modeled the joint effect above and below 19.6 EU/mg for 373 homes that had bedroom floor and bedding endotoxin measurements and data on asthma symptoms. Several recent studies have suggested that the role of endotoxin in asthma may differ for those with allergic asthma and those with non-allergic asthma. We compared diagnosed asthma, asthma symptoms and wheeze in the past year, stratified by allergy status at the household level (self-reported doctor diagnosed allergy). The adjusted odds ratio for wheezing was higher for households with allergic residents that had higher bedding endotoxin (OR=2.16; 95%CI=1.12-4.15; referent is allergic with low endotoxin) as compared to non-allergic wheezing subjects with higher endotoxin exposure (OR=0.80; 95%CI=0.33-1.92; referent is non-allergic with low endotoxin). However, this analysis demonstrated no significant interaction between health outcomes and allergy status (interaction p-value=0.11) (see Table E5 was three-fold higher for households that had a biopail for compostable waste in their kitchen versus those who did not (6) . Endotoxin loads were considerably lower than those in the current study. The LISA study is a birth cohort study of allergy in Munich and Leipzig, Germany in which mattress dust was collected from mothers of newborns (35, 41) . This study yielded a very low geometric mean endotoxin concentration (2.9 EU/mg; n=1884; range 0.057-1290 EU/mg). Exposure to bedding endotoxin in the first few months of life protected against atopic eczema but was a risk factor for respiratory infection, cough with infection and wheezing at 6 months of age (41). By one year of age, the protective effect was no longer apparent, yet the risk of wheezing was still evident in the highest exposure group (>10.2 EU/mg, OR 1.60). The highest quintile group in the LISA study was exposed at the median level found in the current study.
A second large European study, the ALEX study, investigated the role of endotoxin exposure early in life in farm children born in Bavaria, Austria and Switzerland (28) and found that endotoxin concentration in the child's bedding was associated with reduced risk of hay fever, sneezing and itchy eyes. Endotoxin load was further associated with a reduction in atopic sensitization and atopic wheeze.
Asthma and wheeze among non-allergic subjects were non-significantly related to endotoxin exposure. Smoothing plots showing adjusted prevalence of wheeze for bed endotoxin stratified by atopic status demonstrated a protective effect of endotoxin for those with atopy and increased risk of wheeze for non-atopic subjects exposed at the highest endotoxin loads. While not focused on children, data from the current study present a different picture. In the National Survey, both allergic and non-allergic subjects had higher adjusted odds ratios for diagnosed asthma, asthma symptoms, and wheeze in the past year with increasing endotoxin exposure for bedroom floor endotoxin. For bed endotoxin allergic subjects were more likely than non-allergic subjects to wheeze with higher endotoxin concentration. For this analysis none of the interaction terms were significant. It should be pointed out that this study was somewhat underpowered for analysis of health outcomes stratified by both endotoxin exposure and allergy status.
This study had several weaknesses. One limitation of this study is that exposures and health outcomes were assessed cross-sectionally. Health outcome variables were assessed at the same time as dust samples were collected; however, the age of onset of asthma and symptoms was not ascertained. Thus we were not able to establish what endotoxin exposures were prior to the development of asthma.
The fact that wheezing in the past month and year, and current asthma medication use yielded similar results to diagnosed asthma supports the study findings. In addition, the use of self-reporting of doctor diagnosed asthma and hay fever could have led to misclassification due to recall bias.
Multivariate analyses reported above were performed at the household level since the study was designed as a household survey. This analysis makes the assumption that endotoxin levels in bedrooms within a home are comparable. In order to the test the effect of aggregation at the household level we performed two additional analyses. First, we analyzed exposure-outcomes data at the individual level for all subjects. Next, we recognized that we could include more households and individuals Individual level analyses were then performed separately for adults and children. This revealed that the higher prevalence of diagnosed asthma and asthma symptoms was driven mostly by an effect of endotoxin exposure among adults. Since this study was designed as a representative survey for the demographics of the U.S., it was not designed or powered to explore specific hypotheses regarding endotoxin and asthma exacerbation in young children as was done in the LISA and ALEX studies.
The National Survey demonstrates on a national scale that U.S. household endotoxin exposures are high relative to those in Europe and are associated with asthma symptoms, current asthma medication use, and wheezing, but not allergy.
Bedroom floor and bedding endotoxin imparted the greatest risk and no no-effect thresholds could be identified. Table 4 . P values and beta coefficients for unadjusted logistic regression models for presence of health outcomes among anyone in the household using log endotoxin concentration as a continuous variable. Those shown in bold are significant at p 0.05. Table 5 . Odds ratios and 95% confidence intervals from logistic regression models for the presence of health outcomes using endotoxin exposure levels above and below the first quartile for bedroom floor and family room floor endotoxin and the second quartile for the bedroom bedding endotoxin. Model 2 is adjusted for census region, season when sampled, frequency of indoor cigarette smoking, education, poverty, ethnicity, race, a resident child less than 6 years, log(Der p + Der f), log(Can f), log(Fel d). 
Bedroom Floor Endotoxin Bedroom Bedding Endotoxin
Assessment of Health Outcomes
Analyses included seven health outcome variables assessed at the individual level. These were ascertained as previously described (E1): diagnosed hay fever; diagnosed asthma; asthma symptoms past year; current asthma medication use; and wheezing ever, in the past month, and in the past year. Since exposure data were available by household, health outcomes were aggregated to the household level for primary analysis. Verification analyses were performed at the individual level.
Seven dichotomous disease outcomes were analyzed at the household level:
diagnosed hay fever, diagnosed asthma, asthma symptoms past year, current asthma medication use, wheezing ever, in the past month, and in the past year. Household information on asthma and allergy was collected by an administered questionnaire.
Diagnosed asthma was ascertained from the following question, "Has a doctor ever diagnosed anyone in your household with asthma including adults that had childhood asthma?" If answered in the affirmative, the respondent was asked questions about asthma symptoms, wheezing and medication use for each member of the household.
Diagnosed asthma was defined as one or more persons in the household with asthma diagnosed by a doctor at anytime in their lifetimes (yes versus no, where no was no one in the household with diagnosed asthma). Symptomatic asthma was defined as at least one person in the household with doctor diagnosed asthma who had asthma symptoms in the past 12 months (yes versus no, where no was either no one with doctor diagnosed asthma or no diagnosed asthmatic with symptoms in the past 12 months).
Other health outcomes including wheezing and medication use were assessed in a similar fashion. The respondent was also asked to provide allergy information for each household member. Diagnosed allergy was determined from the question, "Has a doctor ever diagnosed you (and other household members) with any allergies?" For each household member with doctor diagnosed allergy, the respondent was asked if the allergy was hay fever (allergic rhinitis), skin allergy, food allergy, or other allergies.
Diagnosed allergy was defined as one or more persons in the household with at least one doctor diagnosed allergy (yes versus no, where no was no one in the household with diagnosed allergy). Hay fever was defined as one or more persons in the household with diagnosed hay fever (yes versus no, where no was either no one with diagnosed allergy or no diagnosed allergic member with hay fever).
Sampling
Each household was visited by two field workers who administered a detailed questionnaire, conducted a home inspection, and collected samples. The questionnaire included information on demographics and health of the residents plus conditions of the home (E1). Dust was sampled by vacuum collection into an in-line filter using a standardized protocol. Dust was sieved (425 µm), aliquoted into 100 mg lots and then frozen at -80°C prior to indoor allergen and endotoxin assays.
Endotoxin analysis
Endotoxin analysis methods have been described previously (E1). Briefly, endotoxin was analyzed on 50mg quantities of sieved dust extracted with 1.0 ml pyrogen-free water containing 0.05% Tween-20. The kinetic chromogenic Limulus amebocyte lysate assay was employed with four two-fold dilutions of the samples and a 12 point standard curve referenced to endotoxin standard EC6 (E2). Selected samples were evaluated for inhibition or enhancement of the bioassay. The lower limit of detection for the assay was 0.001 EU/mg of sieved dust. All samples were assayed by a single analyst who was blinded to information on housing characteristics and asthma outcomes. Following linkage with housing unit and allergen data, 2512 endotoxin determinations were available for statistical analysis.
Additional statistical analysis
Allergen assays generally preceded the endotoxin assays and, in some cases, consumed all the collected dust. As a result, endotoxin determinations were performed on a disproportionate number of samples from households that yielded higher quantities of dust. In order to assess the potential for bias, a set of 85 samples from kitchen floors were assayed from households that yielded very low quantities of dust (<100 mg). This evaluation demonstrated no significant relationship between the quantity of dust recovered in sampling and the concentration of endotoxin in the dust (p=0.81) obviating concerns about bias due to disproportionate use of higher quantity dust samples.
We performed supplemental analyses in order to the test the effect of were 15 regression models defined for the bedroom floor. To test the utility of the imputation, we then fit each model and "predicted" the actual bedroom floor data that we had measured. For all models we found that between 75 and 80% of predicted (imputed) concentrations were correctly classified as above or below the stratification threshold. Then using the R-square values to rank the models we selected the model yielding the highest R-squared for which other data were available. That particular regression model was used to impute values for all the missing bedroom floor data.
Since these models were based on all available data, they exceeded the predictivity of the validation models based described above. This same method was then used to impute values for the bedding. For the bedroom floor 202 households out of 831 were imputed, and for the bedding 320 households were imputed.
RESULTS
Additional results are provided in this online supplement. The relationship of endotoxin concentration to endotoxin load is plotted one against the other separately for the sampling locations in Figure E1 . This shows a linear relationship between the logarithms of the two variables with correlation coefficients of 0.73 for the bedroom floor samples and 0.79 for the bedding samples. The coefficient for family room floor samples was also 0.73 (not shown). These data suggest that either concentration or load could be used as measures of household endotoxin. Since the mass of dust collected was known with greater accuracy than the area sampled, particularly for sofa and kitchen floor, we performed our analyses using endotoxin concentration data. Table E4 from individual level logistic regression models separately for adults and children for the presence of health outcomes using bedroom floor endotoxin exposure levels above and below the first quartile. Thirty-five percent of the subjects in this analysis were less than 18 years old. Table E5 provides data for the relationship between bedroom floor and bedding endotoxin concentration and self-reported doctordiagnosed asthma, asthma symptoms (past 12 months) and wheeze (past 12 months) with stratification by allergy status at the household level. Allergy status was based upon self-reported doctor-diagnosed allergy. This analysis had reduced power due to lower subject numbers and additional stratification. However, the adjusted odds ratio for wheeze in the past month was higher for households with allergic residents that had higher endotoxin as compared to those with non-allergic asthma and higher endotoxin.
This analysis demonstrated no significant interaction between health outcomes and allergy status. Models are adjusted for census region, season when sampled, frequency of indoor cigarette smoking, education, poverty, ethnicity, race, a resident child less than 6 years, log(Der p + Der f), log(Can f), and log(Fel d). For asthma outcomes n=1008 to 1051 for adults and n=525-557 for children. 
